|
Q4 2024
|
35 |
155,344 |
Biohaven Pharmactl Hldg Co L, ALDX, ENTX, I9SA.HA
|
13F-HR
|
2/18/2025 |
000110465925014391 |
|
Q3 2024
|
36 |
215,799 |
APLT, Biohaven Pharmactl Hldg Co L, ALDX, AGI.TO
|
13F-HR
|
11/14/2024 |
000110465924118986 |
|
Q2 2024
|
35 |
148,407 |
APLT, Biohaven Pharmactl Hldg Co L, ALDX, AVDL
|
13F-HR
|
8/14/2024 |
000110465924089595 |
|
Q1 2024
|
34 |
160,736 |
APLT, Biohaven Pharmactl Hldg Co L, ALDX, AVDL
|
13F-HR
|
5/15/2024 |
000110465924061904 |
|
Q4 2023
|
32 |
120,759 |
Biohaven Pharmactl Hldg Co L, ALDX, APLT, AVDL
|
13F-HR
|
2/14/2024 |
000110465924023617 |
|
Q3 2023
|
37 |
96,336 |
ALDX, APLT, Biohaven Pharmactl Hldg Co L, AVDL
|
13F-HR
|
11/14/2023 |
000110465923118123 |
|
Q2 2023
|
27 |
82,489 |
ALDX, Biohaven Pharmactl Hldg Co L, AVDL, HOOK
|
13F-HR
|
8/15/2023 |
000110465923091702 |
|
Q1 2023
|
26 |
64,886 |
ALDX, Biohaven Pharmactl Hldg Co L, AVDL calls, I9SA.HA
|
13F-HR
|
5/15/2023 |
000110465923060827 |
|
Q4 2022
|
21 |
44,310 |
ALDX, Biohaven Pharmactl Hldg Co L, ALT, GDX
|
13F-HR
|
2/14/2023 |
000110465923021561 |
|
Q3 2022
|
33 |
171,139 |
Biohaven Pharmactl Hldg Co L, ALDX, ENTX, ALT
|
13F-HR
|
11/14/2022 |
000110465922118490 |
|
Q2 2022
|
41 |
175,205 |
Biohaven Pharmactl Hldg Co L, ALDX, EIGR, ENTX
|
13F-HR
|
8/15/2022 |
000110465922091332 |
|
Q1 2022
|
41 |
159,335 |
Biohaven Pharmactl Hldg Co L, ENTX, EIGR, Orgenesis, Inc.
|
13F-HR
|
5/16/2022 |
000110465922061328 |
|
Q4 2021
|
38 |
181,975 |
Biohaven Pharmactl Hldg Co L, APLT, ENTX, Orgenesis, Inc.
|
13F-HR
|
2/14/2022 |
000110465922022678 |
|
Q3 2021
|
40 |
200,528 |
Biohaven Pharmactl Hldg Co L, APLT, ENTX, Orgenesis, Inc.
|
13F-HR
|
11/15/2021 |
000110465921139144 |
|
Q2 2021
|
42 |
191,496 |
Biohaven Pharmactl Hldg Co L, APLT, ENTX, CRBP
|
13F-HR
|
8/16/2021 |
000110465921106284 |
|
Q1 2021
|
39 |
153,492 |
Biohaven Pharmactl Hldg Co L, APLT, CRBP, Orgenesis, Inc.
|
13F-HR
|
6/14/2021 |
000110465921080656 |
|
Q4 2020
|
31 |
146,681 |
Biohaven Pharmactl Hldg Co L, APLT, EIGR, CRBP
|
13F-HR
|
2/16/2021 |
000110465921023937 |
|
Q3 2020
|
30 |
122,030 |
Biohaven Pharmactl Hldg Co L, APLT, CRBP, Orgenesis, Inc.
|
13F-HR
|
11/16/2020 |
000110465920125804 |
|
Q2 2020
|
19 |
173,219 |
Biohaven Pharmactl Hldg Co L, CRBP, APLT, ABEO
|
13F-HR
|
8/14/2020 |
000110465920095528 |
|
Q1 2020
|
18 |
106,461 |
Biohaven Pharmactl Hldg Co L, CRBP, APLT, ABEO
|
13F-HR
|
5/15/2020 |
000110465920062559 |
|
Q4 2019
|
18 |
135,430 |
Biohaven Pharmactl Hldg Co L, CRBP, APLT, ABEO
|
13F-HR
|
2/14/2020 |
000110465920022015 |
|
Q3 2019
|
23 |
109,262 |
Biohaven Pharmactl Hldg Co L, CRBP, BX, ABEO
|
13F-HR
|
11/14/2019 |
000110465919064196 |
|
Q2 2019
|
22 |
122,151 |
CRBP, Biohaven Pharmactl Hldg Co L, ABEO, BX
|
13F-HR
|
8/14/2019 |
000114420419040043 |
|
Q1 2019
|
17 |
131,596 |
Biohaven Pharmactl Hldg Co L, CRBP, ABEO, KRYS
|
13F-HR
|
5/15/2019 |
000114420419026565 |
|
Q4 2018
|
15 |
87,900 |
Biohaven Pharmactl Hldg Co L, CRBP, ABEO, KRYS
|
13F-HR
|
2/14/2019 |
000114420419008236 |
|
Q3 2018
|
17 |
118,296 |
CRBP, ABEO, Biohaven Pharmactl Hldg Co L, ALDX
|
13F-HR
|
11/14/2018 |
000114420418059931 |
|
Q2 2018
|
19 |
117,674 |
ABEO, Biohaven Pharmactl Hldg Co L, CRBP, ECOR
|
13F-HR
|
8/14/2018 |
000114420418044640 |
|
Q1 2018
|
13 |
97,391 |
ABEO, CRBP, Biohaven Pharmactl Hldg Co L, AMPE
|
13F-HR
|
5/15/2018 |
000114420418028860 |
|
Q4 2017
|
12 |
113,433 |
ABEO, CRBP, Biohaven Pharmactl Hldg Co L, AMPE
|
13F-HR
|
2/14/2018 |
000114420418008909 |
|
Q3 2017
|
16 |
116,948 |
ABEO, Biohaven Pharmactl Hldg Co L, CRBP, VBLT
|
13F-HR
|
11/14/2017 |
000114420417059028 |
|
Q2 2017
|
15 |
75,436 |
CRBP, Biohaven Pharmactl Hldg Co L, ABEO, AVXL
|
13F-HR
|
8/14/2017 |
000114420417043190 |
|
Q1 2017
|
17 |
66,328 |
CRBP, ABEO, VBLT, AVXL
|
13F-HR
|
5/15/2017 |
000114420417027485 |
|
Q4 2016
|
17 |
56,996 |
CRBP, ABEO, VBLT, AVXL
|
13F-HR
|
2/14/2017 |
000114420417008952 |
|
Q3 2016
|
18 |
57,031 |
CRBP, ABEO, SYN, VBLT
|
13F-HR
|
11/14/2016 |
000114420416134459 |
|
Q2 2016
|
22 |
308,530 |
MDVN, CRBP, SYN, ARCT
|
13F-HR
|
8/15/2016 |
000114420416119396 |
|
Q1 2016
|
22 |
246,277 |
MDVN, SYN, AMPE, CRBP
|
13F-HR
|
5/16/2016 |
000114420416102574 |
|
Q4 2015
|
21 |
269,729 |
MDVN, AMPE, SYN, ARCT
|
13F-HR
|
2/17/2016 |
000114420416083000 |
|
Q3 2015
|
19 |
235,563 |
MDVN, AMPE, SYN, ARCT
|
13F-HR
|
11/16/2015 |
000114420415066011 |
|
Q2 2015
|
19 |
310,193 |
MDVN, SYN, AMPE, Advaxis Inc.
|
13F-HR
|
8/14/2015 |
000114420415049867 |
|
Q1 2015
|
17 |
343,460 |
MDVN, AMPE, SYN, ARCT
|
13F-HR
|
5/15/2015 |
000114420415031597 |
|
Q4 2014
|
14 |
254,119 |
MDVN, AMPE, SYN, ARCT
|
13F-HR
|
2/17/2015 |
000114420415010045 |
|
Q3 2014
|
1 |
2,458 |
Bio Blast Pharma Ltd
|
NEW HOLDINGS
|
12/9/2014 |
000114420414072900 |
|
Q3 2014
|
14 |
254,617 |
MDVN, AMPE, ARCT, KERX
|
13F-HR
|
11/14/2014 |
000114420414068774 |
|
Q2 2014
|
15 |
224,399 |
MDVN, AMPE, ARCT, KERX
|
13F-HR
|
8/14/2014 |
000114420414050192 |
|
Q1 2014
|
16 |
193,229 |
MDVN, AMPE, ARCT, SYN
|
13F-HR
|
5/15/2014 |
000114420414031318 |
|
Q4 2013
|
14 |
198,576 |
MDVN, AMPE, ARCT, KERX
|
13F-HR
|
2/14/2014 |
000114420414009812 |